JP2017511368A5 - - Google Patents

Download PDF

Info

Publication number
JP2017511368A5
JP2017511368A5 JP2016562898A JP2016562898A JP2017511368A5 JP 2017511368 A5 JP2017511368 A5 JP 2017511368A5 JP 2016562898 A JP2016562898 A JP 2016562898A JP 2016562898 A JP2016562898 A JP 2016562898A JP 2017511368 A5 JP2017511368 A5 JP 2017511368A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
grams
stereoisomer
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016562898A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017511368A (ja
JP6678116B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2015/052814 external-priority patent/WO2015159265A1/en
Publication of JP2017511368A publication Critical patent/JP2017511368A/ja
Publication of JP2017511368A5 publication Critical patent/JP2017511368A5/ja
Application granted granted Critical
Publication of JP6678116B2 publication Critical patent/JP6678116B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016562898A 2014-04-18 2015-04-17 抗菌剤を含む医薬組成物 Expired - Fee Related JP6678116B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1407/MUM/2014 2014-04-18
IN1407MU2014 2014-04-18
PCT/IB2015/052814 WO2015159265A1 (en) 2014-04-18 2015-04-17 Pharmaceutical compositions comprising antibacterial agents

Publications (3)

Publication Number Publication Date
JP2017511368A JP2017511368A (ja) 2017-04-20
JP2017511368A5 true JP2017511368A5 (enExample) 2018-06-07
JP6678116B2 JP6678116B2 (ja) 2020-04-08

Family

ID=53276202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016562898A Expired - Fee Related JP6678116B2 (ja) 2014-04-18 2015-04-17 抗菌剤を含む医薬組成物

Country Status (8)

Country Link
US (1) US10857138B2 (enExample)
EP (1) EP3131583A1 (enExample)
JP (1) JP6678116B2 (enExample)
KR (1) KR102173632B1 (enExample)
CN (1) CN107980000A (enExample)
BR (1) BR112016024235A2 (enExample)
MX (1) MX2016013431A (enExample)
WO (1) WO2015159265A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10417727B2 (en) * 2016-09-26 2019-09-17 Uber Technologies, Inc. Network system to determine accelerators for selection of a service
EP3301094A1 (en) * 2016-09-30 2018-04-04 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
RU2019130048A (ru) * 2017-03-02 2021-04-02 Вокхардт Лимитед Антибактериальные соединения
US10085999B1 (en) * 2017-05-10 2018-10-02 Arixa Pharmaceuticals, Inc. Beta-lactamase inhibitors and uses thereof
WO2019093450A1 (ja) * 2017-11-10 2019-05-16 塩野義製薬株式会社 ジアザビシクロオクタン誘導体
KR102769880B1 (ko) 2018-01-25 2025-02-20 쑤저우 시노벤트 파마슈티칼즈 씨오., 엘티디. β-락타마제 억제제 및 그 용도
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
SG11202101255UA (en) 2018-08-09 2021-03-30 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
CA3238268A1 (en) 2021-11-17 2023-05-25 Xufan WANG ?-lactamase inhibitor intermediate and preparation method therefor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US342553A (en) * 1886-05-25 Induction-coil
US2874279A (en) 1952-08-06 1959-02-17 Itt Pulse selector circuit
RU2578370C2 (ru) * 2011-08-27 2016-03-27 Вокхардт Лимитед Производные 1,6- диазабицикло [3,2,1] октан-7-она и их применение при лечении бактериальных инфекционных болезней
MX340533B (es) * 2011-08-30 2016-07-13 Wockhardt Ltd Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
EP3052497B1 (en) 2011-09-13 2017-06-28 Wockhardt Limited Nitrogen containing compounds and their use
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
TW201343645A (zh) 2012-03-30 2013-11-01 Cubist Pharm Inc 1,3,4-□二唑及1,3,4-噻二唑β-內醯胺酶抑制劑
US8916709B2 (en) * 2012-03-30 2014-12-23 Cubist Pharmaceuticals, Inc. 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
RU2693898C2 (ru) 2012-05-30 2019-07-05 Мейдзи Сейка Фарма Ко., Лтд. НОВЫЙ ИНГИБИТОР бета-ЛАКТАМАЗЫ И СПОСОБ ЕГО ПОЛУЧЕНИЯ
RU2676482C2 (ru) 2013-01-14 2018-12-29 Вокхардт Лимитед Композиции и способы лечения бактериальных инфекций

Similar Documents

Publication Publication Date Title
JP2017511368A5 (enExample)
JP2009534386A5 (enExample)
JP2012533546A5 (enExample)
RU2015101102A (ru) Гетероароматическое метильное производное циклического амина
CN105919998B (zh) 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
JP2019526596A5 (enExample)
JP2012513416A5 (enExample)
SI3018132T1 (en) Condensed imidazole derivatives useful as IDO inhibitors
JP2010524932A5 (enExample)
JP2017505293A5 (enExample)
JP2012532136A5 (enExample)
JP2015501833A5 (enExample)
JP2014528464A5 (enExample)
JP2016534148A5 (enExample)
JP2014506907A5 (enExample)
JP2012525431A5 (enExample)
JP2016540742A5 (enExample)
JP2018502906A5 (enExample)
JP2014534981A5 (enExample)
JP2011509301A5 (enExample)
JP2013542267A5 (enExample)
JP2014510147A5 (enExample)
JP2010132677A5 (enExample)
JP2016540811A5 (enExample)
JP2013537240A5 (enExample)